Avita Medical (RCEL) Stock Statistics & Valuation Metrics

Avita Medical has a market cap or net worth of $127.43M. The enterprise value is $95.24M.

Avita Medical has 30,631,794 shares outstanding. The number of shares has decreased by -2.65% in one year.

Avita Medical’s return on equity (ROE) is 2.92 and return on invested capital (ROIC) is -1013.96%.

The current PE Ratio of Avita Medical is ―. Avita Medical’s PEG ratio is 0.07.

In the last 12 months, Avita Medical had revenue of 71.61M and earned -48.59M in profits. Earnings per share was -1.74.

In the last 12 months, operating cash flow was -31.20M and capital expenditures 0.00, giving a free cash flow of -31.20M billion.

Avita Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Avita Medical upcoming earnings date is May 7, 2026, Before Open (Confirmed).

Avita Medical as a current ratio of 0.57, with Debt / Equity ratio of -12.82%

In the past 12 months, Avita Medical has paid -11.00K in taxes.

Avita Medical EV to EBITDA ratio is 1.38, with an EV/FCF ratio of -2.82.

Avita Medical has $18.18M in cash and marketable securities with $2.13M in debt, giving a net cash position of $16.05M billion.

Gross margin is 82.13%, with operating margin of 89.01%, and net profit margin of -67.85%.

The average price target for Avita Medical is $4.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy